Form 8-K - Current report:
SEC Accession No. 0001104659-25-075970
Filing Date
2025-08-11
Accepted
2025-08-11 09:01:01
Documents
17
Period of Report
2025-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523050d1_8k.htm   iXBRL 8-K 43768
2 EXHIBIT 10.1 tm2523050d1_ex10-1.htm EX-10.1 258412
3 EXHIBIT 10.2 tm2523050d1_ex10-2.htm EX-10.2 111774
4 EXHIBIT 10.3 tm2523050d1_ex10-3.htm EX-10.3 122128
5 EXHIBIT 10.4 tm2523050d1_ex10-4.htm EX-10.4 132399
6 EXHIBIT 99.1 tm2523050d1_ex99-1.htm EX-99.1 10079
  Complete submission text file 0001104659-25-075970.txt   1007103

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20250809.xsd EX-101.SCH 3026
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20250809_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20250809_pre.xml EX-101.PRE 22366
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2523050d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 251200420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)